Funded Startups in Mecklenburg-Vorpommern
Among the 11 most recent disclosed rounds in Mecklenburg-Vorpommern, the largest disclosed amount is Cheplapharm Arzneimittel’s $544M convertible note (202…
Among the 11 most recent disclosed rounds in Mecklenburg-Vorpommern, the largest disclosed amount is Cheplapharm Arzneimittel’s $544M convertible note (2022-10-25). That figure dwarfs the next-largest disclosed rounds: Centogene’s $45M (2022-02-01) and Zasta’s $65M (2023-01-17), with most other disclosed amounts clustered between $1M and $11M (e.g., Duschkraft $1M on 2021-05-20; Hepster $11M on 2023-07-10; Zasta’s $65M stands out as a separate high point).
Geographically, all 11 rows are tied to only two cities—primarily Rostock (Artcline, AIM3D, Fischer, Hepster, Hepster again, Centogene, Duschkraft, Sawayo) with additional presence in Schwerin (Arztkonsultation AK) and Greifswald (Cheplapharm Arzneimittel). Temporally, the list spans 2021-02-24 to 2025-09-13, with two notable round-date clusters: three entries in 2023 alone (AIM3D 2023-07-10, Hepster 2023-07-10, and Fischer 2023-04-03) and multiple financial-services appearances centered on Hepster (Series A 2021-03-05 and Series B 2023-07-10) plus Zasta (2023-01-17). Stage information is incomplete in several rows: 2 entries are “undisclosed” and 5 are labeled “Series Unknown.”
Most recent rounds
11 shownRelated listings
Frequently asked
What stands out on deal size in this Mecklenburg-Vorpommern list, and how does it compare to the rest of the disclosed rounds?
Cheplapharm Arzneimittel’s $544M convertible note (2022-10-25) is the clear outlier, far above the next-largest disclosed amounts in the rows: Zasta at $65M (2023-01-17) and Centogene at $45M (2022-02-01). Outside these, disclosed rounds mostly sit in the $1M–$11M range (e.g., Duschkraft $1M on 2021-05-20; Hepster $10M on 2021-03-05; Hepster $11M on 2023-07-10).
Are there city or sector concentrations that repeat across multiple entries?
Rostock dominates the geography, appearing in 8 of the 11 rows (Artcline 2025-09-13; Hepster 2023-07-10 and 2021-03-05; Centogene 2022-02-01; among others), while Schwerin (Arztkonsultation AK, 2024-02-20) and Greifswald (Cheplapharm Arzneimittel, 2022-10-25) each appear once. In sector terms, Financial Services repeats with Hepster (2021-03-05 Series A $10M and 2023-07-10 Series B $11M) and Zasta (2023-01-17, $65M).
Which companies recur with multiple rounds in the most recent dataset, and what does that imply for follow-on activity?
Hepster appears twice with different stages and dates in this set: Series A on 2021-03-05 for $10M and Series B on 2023-07-10 for $11M. Zasta appears once (Series Unknown on 2023-01-17 for $65M), and no other company repeats, so the clearest “multi-round” signal in these 11 rows is Hepster.
How much of the list falls into the newest part of the timeline, and which entry is the latest overall?
The most recent entry across the rows is Artcline’s convertible note on 2025-09-13 for $6M. Looking only at the shown window, there are two entries in 2024 (Arztkonsultation AK on 2024-02-20 for $540K, plus the next-latest is in 2023), while the bulk of dated rounds are concentrated in 2021–2023 (e.g., Centogene 2022-02-01 $45M; Cheplapharm 2022-10-25 $544M; Duschkraft 2021-05-20 $1M).
What does the stage labeling look like here—are most rounds categorized or left ambiguous?
Stage labeling is mixed: 5 of the 11 rows are marked “Series Unknown” (AIM3D 2023-07-10; AIM3D is undisclosed but labeled as Series Unknown?—the row shows Series Unknown; plus Arztkonsultation AK 2024-02-20; Zasta 2023-01-17; Fischer is Seed; and Cheplapharm is Convertible Note), and 2 are explicitly “undisclosed” on the amount (AIM3D 2023-07-10; Fischer 2023-04-03). Disclosed, named stages do include Series B for Hepster ($11M on 2023-07-10) and Seed for Sawayo ($2M on 2021-02-24).
Are there unusually small disclosed rounds compared with the rest of the disclosed amounts?
Yes: the smallest disclosed amount shown is Duschkraft’s $1M on 2021-05-20. Several other disclosed rounds are still relatively small (e.g., $2M Sawayo on 2021-02-24; $6M Artcline on 2025-09-13; $10M Hepster on 2021-03-05), but Duschkraft is the low end among disclosed figures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.